Company
Acesion Pharma
Acesion Pharma is on a mission to develop novel therapies designed to treat atrial fibrillation, safely.
Also known as Acesion Pharma ApS
- Status
- Operatingas of 2026-09-20
- Business model
- B2B
- Headquarters
- Copenhagen, Denmark
- Founded
- 2011
- Legal name
- Acesion Pharma ApS
Claim, correct or request removal
Record updated 28 September 2026
About
Acesion Pharma ApS is a Danish biotech company founded in 2011 and based in Copenhagen. Our technology is based on research initiated in 2008 at University of Copenhagen and chemistry insights from the company Neurosearch. Acesion Pharma aims to develop more efficacious and safe drugs for the treatment of atrial fibrillation (AF), the most common type of cardiac arrhythmia.
Funding snapshot
- Latest round
- Series B2023-09-26
Funding rounds
- Series B
- 2023-09-26
- Grant
- 2019-03-12
Loading relationship preview